Published in Mult Scler on August 13, 2008
Long-term decrease in VLA-4 expression and functional impairment of dendritic cells during natalizumab therapy in patients with multiple sclerosis. PLoS One (2012) 0.85
Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation. Neurol Sci (2011) 0.77
Head tremor secondary to MS resolved with rituximab. Neurol Sci (2011) 0.76
Re: early relapses after the first dose of natalizumab in active multiple sclerosis. Mult Scler (2009) 0.75
Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumab. Clinicoecon Outcomes Res (2009) 0.75
Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res (1986) 8.69
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology (2009) 2.58
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects. Neurology (2004) 2.04
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol (2011) 1.93
Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension (1988) 1.90
Entropy, entropy rate, and pattern classification as tools to typify complexity in short heart period variability series. IEEE Trans Biomed Eng (2001) 1.81
The elusive pathophysiology of neurally mediated syncope. Circulation (2000) 1.81
Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med (1999) 1.68
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. Neurology (2011) 1.68
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis. Neurology (1999) 1.65
Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis. Neurology (1998) 1.58
Sympathetic and baroreceptor reflex function in neurally mediated syncope evoked by tilt. J Clin Invest (1997) 1.52
Circulating adhesion molecules and carotid artery structural changes in patients with noninsulin-dependent diabetes mellitus. J Hum Hypertens (2003) 1.51
Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines. J Infect Dis (1999) 1.36
Activation of C-C beta-chemokines in human peripheral blood gammadelta T cells by isopentenyl pyrophosphate and regulation by cytokines. Blood (2000) 1.31
Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study. Circulation (2001) 1.31
CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes. J Immunol (1997) 1.30
Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci (1994) 1.27
SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells. Oncogene (2011) 1.25
Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens (1995) 1.22
Malignant vagotonia due to selective baroreflex failure. Hypertension (1997) 1.20
Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials. J Neurol Sci (1999) 1.20
The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology (2004) 1.20
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis. Gene Ther (2008) 1.18
Changing prognosis of primary intracerebral hemorrhage: results of a clinical and computed tomographic follow-up study of 104 patients. Stroke (1988) 1.17
Quantifying the strength of the linear causal coupling in closed loop interacting cardiovascular variability signals. Biol Cybern (2002) 1.16
Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Mult Scler (2011) 1.16
Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial. Neurology (2010) 1.15
Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors. J Immunol (1997) 1.15
Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult Scler (2009) 1.13
Model for the assessment of heart period and arterial pressure variability interactions and of respiration influences. Med Biol Eng Comput (1994) 1.12
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome. J Neurol (1997) 1.12
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study. Mult Scler (2013) 1.12
The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis. Cell Death Differ (2009) 1.12
Various ways of calculating echocardiographic left ventricular mass and their relative prognostic values. J Hypertens (1998) 1.12
Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology (1995) 1.12
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. Mult Scler (2011) 1.11
HLA-class I markers and multiple sclerosis susceptibility in the Italian population. Genes Immun (2009) 1.09
Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. J Neuroimmunol (2001) 1.09
Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis. Clin Exp Immunol (2009) 1.09
Individual recognition by heart rate variability of two different autonomic profiles related to posture. Circulation (1997) 1.04
Targeting alphavbeta3 integrin: design and applications of mono- and multifunctional RGD-based peptides and semipeptides. Curr Med Chem (2010) 1.04
Heterogeneity of autoantibodies in stiff-man syndrome. Ann Neurol (1993) 1.03
Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance. Circulation (1999) 1.02
Early occupational therapy programme increases hand grip strength at 3 months: results from a randomised, blind, controlled study in early rheumatoid arthritis. Ann Rheum Dis (2008) 1.01
Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab. Eur J Neurol (2012) 1.00
Innate T-cell immunity to nonpeptidic antigens. Immunol Today (1998) 1.00
IL-12-mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of V delta 2+ TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patients. J Immunol (1999) 1.00
Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry (1996) 0.99
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther (2001) 0.99
Effect of standing on neurohumoral responses and plasma volume in healthy subjects. J Appl Physiol (1985) (1998) 0.99
Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration. Mult Scler (2013) 0.97
Variations of the perforin gene in patients with multiple sclerosis. Genes Immun (2008) 0.96
Effects of standing on cerebrovascular resistance in patients with idiopathic orthostatic intolerance. Am J Med (1999) 0.95
Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesions. AJNR Am J Neuroradiol (1997) 0.95
Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry (2005) 0.95
Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. Magn Reson Imaging (1999) 0.95
Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine. Pain (1991) 0.95
Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. The Vobarno Study. Circulation (1995) 0.94
The effect of Bacille Calmette-Guérin on the evolution of new enhancing lesions to hypointense T1 lesions in relapsing remitting MS. J Neurol (2003) 0.93
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis. Br J Pharmacol (2012) 0.92
Interscanner variation in brain MRI lesion load measurements in MS: implications for clinical trials. Neurology (1997) 0.92
Spectral analysis of R-R and arterial pressure variabilities to assess sympatho-vagal interaction during mental stress in humans. J Hypertens Suppl (1989) 0.92
Cytokines and immunity in multiple sclerosis: the dual signal hypothesis. J Neuroimmunol (2000) 0.91
Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results. J Neurol Neurosurg Psychiatry (1999) 0.91
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability. J Neurol Sci (2000) 0.91
Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-beta1a. J Interferon Cytokine Res (1998) 0.91
Recombinant human insulin-like growth factor I exerts a trophic action and confers glutamate sensitivity on glutamate-resistant cerebellar granule cells. Proc Natl Acad Sci U S A (1993) 0.90
Home based management in multiple sclerosis: results of a randomised controlled trial. J Neurol Neurosurg Psychiatry (2002) 0.90
Serum amyloid A protein is elevated in relapsing-remitting multiple sclerosis. J Neuroimmunol (1998) 0.90
A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy. Genes Immun (2007) 0.89
Chromosome imbalance, normal phenotype, and imprinting. J Med Genet (1990) 0.89
Curcumin inhibits activation of Vgamma9Vdelta2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation. J Immunol (2001) 0.89
A hypothesis: autonomic rhythms are reflected in growth lines of teeth in humans and extinct archosaurs. Auton Neurosci (2005) 0.89
Microbe exposure, innate immunity and autoimmunity. Immunol Today (1999) 0.89
Low and high frequency components of blood pressure variability. Ann N Y Acad Sci (1996) 0.88
Development of a method for measuring cell number: application to CNS primary neuronal cultures. Cytometry (1994) 0.88
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta. Eur J Neurol (2002) 0.88
'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence. Eur J Neurol (2003) 0.88
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis. Hum Gene Ther (2001) 0.88
Bilateral eighth cranial nerve neuropathy in human immunodeficiency virus infection. J Neurol (1993) 0.88
N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity. Kidney Int (2006) 0.88
Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss. J Neuroimmunol (2009) 0.87
Italian population yields world's largest twin registry. Nat Med (1997) 0.87
Relationship between emotional distress in caregivers and health status in persons with multiple sclerosis. Mult Scler (2004) 0.87
Noninvasive assessment of mitoxantrone cardiotoxicity in relapsing remitting multiple sclerosis. J Clin Pharmacol (1995) 0.87
Thymoma-associated immunodeficiency: a syndrome characterized by severe alterations in NK, T and B-cells and progressive increase in naïve CD8+ T Cells. Int J Immunopathol Pharmacol (2010) 0.87
Assessment of the neural control of the circulation during psychological stress. J Auton Nerv Syst (1991) 0.87
Fatigue and magnetic resonance imaging activity in multiple sclerosis. J Neurol (1999) 0.86
Contrast-enhanced magnetic resonance activity in relapsing remitting multiple sclerosis patients: a short term natural history study. Mult Scler (2000) 0.86
Quantitative magnetic resonance analysis in vascular dementia. J Neurol (1997) 0.86
Analysis of neural mechanisms accompanying different intensities of dynamic exercise. Chest (1992) 0.86